|
1
|
Maratou E, Hadjidakis DJ, Kollias A,
Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E,
Nikzas D, et al: Studies of insulin resistance in patients with
clinical and subclinical hypothyroidism. Eur J Endocrinol.
160:785–790. 2009. View Article : Google Scholar
|
|
2
|
Fernandez-Real JM, Lopez-Bermejo A, Castro
A, Casamitjana R and Ricart W: Thyroid function is intrinsically
linked to insulin sensitivity and endothelium-dependent
vasodilation in healthy euthyroid subjects. J Clin Endocrinol
Metab. 91:3337–3343. 2006. View Article : Google Scholar
|
|
3
|
Roos A, Bakker SJ, Links TP, Gans RO and
Wolffenbuttel BH: Thyroid function is associated with components of
the metabolic syndrome in euthyroid subjects. J Clin Endocrinol
Metab. 92:491–496. 2007. View Article : Google Scholar
|
|
4
|
Dimitriadis G, Mitrou P, Lambadiari V,
Boutati E, Maratou E, Panagiotakos DB, Koukkou E, Tzanela M,
Thalassinos N and Raptis SA: Insulin action in adipose tissue and
muscle in hypothyroidism. J Clin Endocrinol Metab. 91:4930–4937.
2006. View Article : Google Scholar
|
|
5
|
Jornayvaz FR, Lee HY, Jurczak MJ, Alves
TC, Guebre-Egziabher F, Guigni BA, Zhang D, Samuel VT, Silva JE and
Shulman GI: Thyroid hormone receptor-α gene knockout mice are
protected from diet-induced hepatic insulin resistance.
Endocrinology. 153:583–591. 2012. View Article : Google Scholar
|
|
6
|
Stanická S, Vondra K, Pelikánová T, Vlcek
P, Hill M and Zamrazil V: Insulin sensitivity and
counter-regulatory hormones in hypothyroidism and during thyroid
hormone replacement therapy. Clin Chem Lab Med. 43:715–720. 2005.
View Article : Google Scholar
|
|
7
|
Handisurya A, Pacini G, Tura A, Gessl A
and Kautzky-Willer A: Effects of T4 replacement therapy on glucose
metabolism in subjects with subclinical (SH) and overt
hypothyroidism (OH). Clin Endocrinol (Oxf). 69:963–969. 2008.
View Article : Google Scholar
|
|
8
|
Dessein PH, Joffe BI and Stanwix AE:
Subclinical hypothyroidism is associated with insulin resistance in
rheumatoid arthritis. Thyroid. 14:443–446. 2004. View Article : Google Scholar
|
|
9
|
Finucane JF: Carbohydrate tolerance in
autoimmune thyroiditis. Diabetes. 24:829–832. 1975. View Article : Google Scholar
|
|
10
|
Kornete M, Mason ES and Piccirillo CA:
Immune regulation in T1D and T2D: Prospective role of foxp3+ treg
cells in disease pathogenesis and treatment. Front Endocrinol
(Lausanne). 4:762013.
|
|
11
|
Herold KC, Hagopian W, Auger JA,
Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu
D, Zivin RA and Bluestone JA: Anti-CD3 monoclonal antibody in
new-onset type 1 diabetes mellitus. N Engl J Med. 346:1692–1698.
2002. View Article : Google Scholar
|
|
12
|
Penaranda C, Tang Q and Bluestone JA:
Anti-CD3 therapy promotes tolerance by selectively depleting
pathogenic cells while preserving regulatory T cells. J Immunol.
187:2015–2022. 2011. View Article : Google Scholar :
|
|
13
|
Herold KC, Gitelman S, Greenbaum C, Puck
J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E,
Seyfert-Margolis V, et al: Treatment of patients with new onset
type 1 diabetes with a single course of anti-CD3 mAb Teplizumab
preserves insulin production for up to 5 years. Clin Immunol.
132:166–173. 2009. View Article : Google Scholar :
|
|
14
|
Pescovitz MD, Greenbaum CJ,
Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA,
Marks JB, McGee PF, Moran AM, et al: Rituximab, B-lymphocyte
depletion, and preservation of beta-cell function. N Engl J Med.
361:2143–2152. 2009. View Article : Google Scholar
|
|
15
|
Winer DA, Winer S, Shen L, Wadia PP,
Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, et al: B
cells promote insulin resistance through modulation of T cells and
production of pathogenic IgG antibodies. Nat Med. 17:610–617. 2011.
View Article : Google Scholar :
|
|
16
|
Filaci G, Fravega M, Negrini S, Procopio
F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, et
al: Nonantigen specific CD8+ T suppressor lymphocytes originate
from CD8+CD28- T cells and inhibit both T-cell proliferation and
CTL function. Hum Immunol. 65:142–156. 2004. View Article : Google Scholar
|
|
17
|
Yang M, Rui K, Wang S and Lu L: Regulatory
B cells in autoimmune diseases. Cell Mol Immunol. 10:122–132. 2013.
View Article : Google Scholar :
|
|
18
|
Mizoguchi A, Mizoguchi E, Takedatsu H,
Blumberg RS and Bhan AK: Chronic intestinal inflammatory condition
generates IL-10-producing regulatory B cell subset characterized by
CD1d upregulation. Immunity. 16:219–230. 2002. View Article : Google Scholar
|
|
19
|
Mizoguchi A and Bhan AK: A case for
regulatory B cells. J Immunol. 176:705–710. 2006. View Article : Google Scholar
|
|
20
|
Kalampokis I, Yoshizaki A and Tedder TF:
IL-10-producing regulatory B cells (B10 cells) in autoimmune
disease. Arthritis Res Ther. 15 Suppl 1:S12013. View Article : Google Scholar :
|
|
21
|
Shi L, Bi M, Yang R, Zhou J, Zhao S, Fan
C, Shan Z, Li Y and Teng W: Defective expression of regulatory B
cells in iodine-induced autoimmune thyroiditis in non-obese
diabetic H-2(h4) mice. J Endocrinol Invest. 37:43–50. 2014.
View Article : Google Scholar
|
|
22
|
Lin Y and Sun Z: Thyroid hormone
potentiates insulin signaling and attenuates hyperglycemia and
insulin resistance in a mouse model of type 2 diabetes. Br J
Pharmacol. 162:597–610. 2011. View Article : Google Scholar :
|
|
23
|
Slatosky J, Shipton B and Wahba H:
Thyroiditis: Differential diagnosis and management. Am Fam
Physician. 61:1047–1052, 1054. 2000.
|
|
24
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part. 1:Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med 15:
539–553. 1998.
|
|
25
|
Samuel VT and Shulman GI: Mechanisms for
insulin resistance: Common threads and missing links. Cell.
148:852–871. 2012. View Article : Google Scholar :
|
|
26
|
Bergman RN, Ader M, Huecking K and Van
Citters G: Accurate assessment of beta-cell function: The
hyperbolic correction. Diabetes. 51 Suppl 1:S212–S220. 2002.
View Article : Google Scholar
|
|
27
|
Kintscher U, Hartge M, Hess K,
Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth
TF, Dragun D, Skurk T, et al: T-lymphocyte infiltration in visceral
adipose tissue: A primary event in adipose tissue inflammation and
the development of obesity-mediated insulin resistance.
Arterioscler Thromb Vasc Biol. 28:1304–1310. 2008. View Article : Google Scholar
|
|
28
|
Pickup JC: Inflammation and activated
innate immunity in the pathogenesis of type 2 diabetes. Diabetes
Care. 27:813–823. 2004. View Article : Google Scholar
|
|
29
|
Jagannathan M, McDonnell M, Liang Y,
Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal
LM and Nikolajczyk BS: Toll-like receptors regulate B cell cytokine
production in patients with diabetes. Diabetologia. 53:1461–1471.
2010. View Article : Google Scholar :
|
|
30
|
DeFuria J, Belkina AC, Jagannathan-Bogdan
M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel
KJ, Watkins AA, Zhu M, et al: B cells promote inflammation in
obesity and type 2 diabetes through regulation of T-cell function
and an inflammatory cytokine profile. Proc Natl Acad Sci USA.
110:pp. 5133–5138. 2013; View Article : Google Scholar :
|
